1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000517:prevention & control; D002177:Candidiasis / Q000150:complications / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D003047:Coccidioidomycosis / Q000150:complications / Q000517:prevention & control; D003453:Cryptococcosis / Q000150:complications / Q000517:prevention & control; D003457:Cryptosporidiosis / Q000150:complications / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000150:complications / Q000517:prevention & control; D005260:Female; D006660:Histoplasmosis / Q000150:complications / Q000517:prevention & control; D006801:Humans; D007223:Infant; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000517:prevention & control; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012008:Recurrence; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000517:prevention & control; D014777:Virus Diseases / Q000150:complications / Q000517:prevention & control
D000890:Anti-Infective Agents